Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

NCT07609706

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

NCT07609446

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

FLASH Pilot Phase 1 Safety Study

NCT07608549

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT07601607

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma

NCT07600151

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Not yet recruiting

Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.

NCT07593482

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Kantonsspital Aarau Aarau, Switzerland

Universitätsspital Basel Basel, Switzerland

Ente Ospedaliero Cantonale (EOC)-Istituto Oncologico della Svizzera Italiana (IOSI) Bellinzona, Switzerland

Inselspital Bern - Universitätsklinik für Medizinische Onkologie Bern, Switzerland

View Trial Details

Not yet recruiting

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

NCT07583810

Conditions: Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Extranodal Marginal Zone Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not yet recruiting

A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide

NCT07585747

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Shenzhen Second People's Hospital Shenzhen, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

Qilu Hospital of Shandong Province Jinan, Shandong, China

View Trial Details

Not yet recruiting

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

NCT07517705

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Fred & Pamela Buffet Cancer Center Omaha, Nebraska, United States

View Trial Details

Not yet recruiting

Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT07584850

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions